Addiction

Addiction is a chronic, progressive disease characterized by craving, abnormal goal-directed behaviours, loss of control including the ability to regularly abstain, relapse, and use despite adverse consequences.[1][2] The human cost is enormous: a 2013 World Health Organization report estimated that drugs accounted for over 12% of deaths worldwide in 2002.[3]

The pathologies of addiction are not clear. It is known that the brain circuitry and its neurotransmitters undergo permanent changes. It is certain, though, that the nucleus accumbens and the ventral tegmental area are involved in developing and maintaining addiction. Evidence shows that there is a strong correlation between the ventral tegmental area and triggering behavioural sensitization in addiction. On the other hand, there is evidence that the nucleus accumbens is critical in the expression of behavioural sensitization.[4] Dopamine plays an important role in addiction as the dopaminergic reward pathways are targeted by every drug of abuse. More specifically, dopamine D2 autoreceptors have been found to play a modulatory role in addiction by regulating dopamine levels, drug sensitivity and performance on cognitive tasks.[5][6]

In addition, a “window of vulnerability” exists for addiction in the adolescent years. A number of factors are implicated, including the rapid structural and development changes occurring in adolescence[7] and rapid changes in social behaviour and increased risk-taking.[8] Binge drinking is of particular concern given its popularity with this age group, and is associated with an increased likelihood of addiction and depression.

While genetic factors and age of initiation are factors in the probability of addiction,[9] the particular drug of abuse carries different risk factors for addiction with estimates ranging from 10–40%. Specific drug pathologies are not homogeneous. Abuse of prescription drugs incorporates misuse mainly as they are the most accessible.[10] The abused drugs include opioids such as oxycodone, tranquilizers such as Xanax, as well as stimulants such as amphetamine.[11] Statistically, abuse begins after the age of abuse of marijuana and alcohol,[9] which may be due to neurobiology and perhaps genetic factors specific to each. There are noted causes for abuse, which will be discussed. Methods of prevention for prescription drug abuse exist and are interrelated to reasons why Medical Toxicologists may inaccurately prescribe to individuals.[12] Caffeine addiction is an example of substance-specific addiction (as opposed to time-specific addiction such as adolescent addiction). Caffeine exerts its action mainly through competitive inhibition of the adenosine receptor which leads to a decrease or increase in cAMP depending on the receptor subtype. Improved cognition but also craving for caffeine are believed to occur through dopamine-dependent pathways. Tolerance occurs when adenosine receptors are up-regulated.

Current treatments for addiction include both behavioural and pharmaceutical approaches. Although some progress is being made, treatment efficacy is limited and better understanding is needed of the neurobiological pathways in the development and perpetuation of addiction. Current treatments for addiction include both behavioural and pharmaceutical approaches. Although some progress is being made, treatment efficacy is still limited. Successful recovery often requires the incorporation of multiple methods to create a holistic treatment plan, while adolescent addiction treatment requires additional considerations, to encompass the complex nature of addiction.

Bibliography
1. American Society of Addiction Medicine. Definition of Addiction.http://www.asam.org/for-the-public/definition-of-addiction (2011)
3. WHO. Management of Substance Abuse: The Global Burden. http://www.who.int/substance_abuse/facts/global_burden/en/ (2013)
4. Kauer, J.A., Malenka, R.C. Synaptic plasticity and addiction. Nature 8 844-858 (2007)
5. Bello, E.P. et al. Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors. Nature Neuroscience 14(8) 1033-1038 (2011)
6. Briand, L.A. et al. Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine. Neuropsychopharmacology 33(12) 2969-2980 (2008)
7. Casey, B.J., Galvan, A., Hare, T.A. Changes in Cerebral Functional Organization During Cognitive Development. Current Opinion in Neurobiology 15 239-244 (2005)
8. Nees F, et al. Determinants of Early Alcohol Use In Health Adolescents: The Differential Contribution of Neuroimaging and Psychological Factors. Neuropsychopharmacology 37 986-995 (2012)
9. Chlorian, D.B. et al. Genetic and Neurophysiological Correlates of the Age of Onset of Alcohol Use Disorders in Adolescents and Young Adults. Behav. Genet. 43 386-401 (2013)
10. Mendelson J. et al. Addiction to prescription opioids: Characteristics of the emerging epidemic and treatment with buprenorphine. Experimental and Clinical Psychopharmacology 16(5) 435-441 (2008)
11. Lankenau, S.E. et al. Patterns of prescription drug misuse among young injection drug users. Journal of Urban Health: Bulletin of the New York Academy of Medicine 89(6) 1004-1016 (2012)
12. Perrone, J., DeRoos, F.J., Nelson, L.S. Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012. Journal of Medical Toxicology: Official Journal of the American College of Medical Toxicology 8(4) 341-352 (2012)


Adolescents and Addiction

main article: Adolescents and Addiction
author: BSwaffer
Adolescence is a time of life associated with many changes both physically and behaviourally. It is defined by the World Health Organization as the age between 10-19 years of age, but more broadly, researchers define adolescence as anywhere between 10-24, which correlates to the age at which scientists feel the brain has fully matured. The behavioural changes, including risk taking and sensation seeking often associated with adolescence, concomitant with the dramatic physical changes occurring in the brain create a the window of vulnerability. The combination of adolescent-onset drug use and this vulnerability results in a significantly higher rate of lifetime addiction. If drug use is initiated under the age of 13, for example, the probability of a lifetime abuse problems is about 35%, decreasing substantially to 15% if the age of onset is 17 years old; by adulthood a person is four times less likely to have an addiction problem than the early onset users.[1] These figures illustrate the importance in understanding the causes and implications of adolescent drug use and that adolescents seem to be highly vulnerable to forming addictions. Governments around the world are concerned with the personal, social, and health costs related to addiction and much research effort is directed towards causes and prevention. The implications of recent studies suggesting that adolescent drug onset is becoming younger are therefore particularly concerning.[2]

Adolescent Addiction Stories
Figure 1, Foundation for a Drug Free World
Bibliography
1. Grant, B.F. & Dawson, D.A. Age of onset of drug use and its association with DSM-IV drug abuse and dependence: results from the national longitudinal alcohol epidemiologic survey. Journal of Substance Abuse. 10, 163-173 (1998).
2. Muck, R. et al. An overview of the effectiveness of adolescent substance abuse treatment models. Youth & Society. 33, 143-168 (2001).


Caffeine Addiction

main article: Caffeine Addiction
author: Alexandra Marinova

Image Unavailable

Caffeine is the most widely consumed psychoactive substance with approximately 80% of the American population (adults and children) ingesting it on a regular basis[1] . It is a legal stimulant drug that affects the central nervous system and has well-recognized addictive properties [2] . Because of this and its high availability, the mechanisms through which it induces physical dependence (tolerance ) and triggers drug-seeking behavior are important to study.

There are 4 proposed mechanisms through which caffeine exerts its physiological effects:
1 GABA-A receptor inhibition [3]
2 Direct intracellular calcium release [4]
3 Phosphodiesterases inhibition [5]
4 Adenosine receptor antagonism [6]

Antagonism of adenosine receptors in the brain is the most likely mechanism through which caffeine exerts its effects under normal physiological conditions. The other mechanisms are significant only at higher caffeine plasma concentration not common in everyday use (see figure 1). Therefore, this neurowiki will focus on adenosine receptors inhibition by caffeine.

Capture.PNG
Bibliography
1. Frary et al (2005) Food sources and intakes of caffeine in the diets of persons in the United States. J. Am. Diet. Assoc. 105, 110–113.
2. Griffiths, R.R., Juliano, L.M., Chausmer, A., (2003) Caffeine: pharmacology and clinical effects. In: Graham, A.W., Schultz, T.K., Mayo-Smith, M.F., Ries, R.K., Wilford, B.B. (Eds.), Principles of Addiction Medicine, 3rd ed. American Society of Addiction Medicine, pp. 193–224.
3. Fredholm, B. B. (1980). Are methylxanthine effects due to antagonism of endogenous adenosine? Trends Pharmacol. Sci. 1, 129-132
4. McPherson P. S., et al. (1991). The brain ryanodine receptor: a caffeine-sensitive calcium release channel. Neuron. 7: 17-25
5. Debry G (1994) Coffee and Health. Paris: John Libbey Eurotext
6. Fredholm BB (1995) Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine. Pharmacology and Toxicology, 76, 93-101.


Plasticity in Addiction

main article: Plasticity in Addiction
author: Megan Montifar

Brain on Drugs [4]
Image Unavailable

Synaptic plasticity within the mesolimbic dopamine system is known to cause critical adaptations underlying addiction. Many studies show that these neural adaptations develop after prolonged drug use over a long period time and that these adaptations can affect the brain circuitry permanently.[1] Plasticity, within the realm of addiction, not only affects the circuitry of the brain, but they can also have long-lasting effects on the individual’s behaviour.[2] These prolonged drug experiences presented on the brain leave traces within the circuitry that lead to the development and the persistence of addiction.[3] Various studies have shown that the LTP and LTD have significant roles in the learning and memory pathways, which are two basic pathways that contribute to the persistence of the behavioural abnormalities that underlie addiction, as well as the synaptic plasticity within the brain.[1]The mesolimbic dopamine system is important, not only as a major site of that addictive drugs act on, but also as a system in converting “motivations into goal-directed actions.”[3] Within the mesolimbic dopamine system, the ventral tegmental area, nucleus accumbens and prefrontal cortex are the major structures that are affected and changed by addictive drugs.[3] In addition, studies have shown that other structures in the brain, such as the bed nucleus of the stria terminalis and the amygdala, as well as the hippocampus, contribute to the reward process and the learning and memory pathways.[2][3] Furthermore, the neurons involved in the development of addiction play an important role by facilitating the initial changes in the brain, which lead to the permanent synaptic plasticity underlying addiction.

Bibliography
1. Kauer JA, Malenka RC. Synaptic plasticity and addiction. Nature. (2007) 8:844-858.
2. Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nature Reviews Neuroscience. (2001) 2:119-128.
3. Lücher C, Malenka RC. Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron. (2011) 69(4):650-663.


Prescription Drug Addiction

main article: Prescription Drug Addiction
author: Matilda Shonibare

Non-Medical Abuse of Prescription Drugs
Image Unavailable
Prescribed Pills. Image Source: addictionsearch.com

Addiction presents itself in numerous forms. In fact, there are a plethora of addictions, such as caffeine-addiction, that are already known to the public. Of these possible addictions, prescription drug addiction is a pressing matter. It is prevalent in adolescent demographics[1] (adolescents-and-addiction). In fact, prescription drug abuse is becoming a major public health issue. This matter is of vital importance due to the fact that it is predominant in the youth of society for the focal reason of possessing the characteristic of being highly accessible.[2] There is an abundance of abused drugs. Some of these drugs include opioids (i.e., Morphine), tranquilizers (i.e., Valium), as well as stimulants (i.e., Ritalin).[3] Prescription drug addiction demonstrates high relevance to society and as such, is not taken lightly in regards to its detrimental effects on the adolescent demographic.

The Death of One Adolescent and its Effect on Another
Video source: Youtube.com
Bibliography
1. Zosel, A., Bartelson, B. B., Bailey, E., Lowenstein, S., & Dart, R. (2013). Characterization of adolescent prescription drug abuse and misuse using the researched abuse diversion and addiction-related surveillance (RADARS(®)) system. Journal of the American Academy of Child and Adolescent Psychiatry, 52(2), 196-204.
2. Mendelson, J., et al. (2008). Addiction to prescription opioids: Characteristics of the emerging epidemic and treatment with buprenorphine. Experimental and Clinical Psychopharmacology, 16(5), 435-441.
3. Lankenau, S. E., et al. (2012). Patterns of prescription drug misuse among young injection drug users. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 89(6), 1004-1016.


The Role of Dopamine D2 Receptors

main article: The Role of Dopamine D2 Receptors
author: Shaheem Alam

Dopamine D2 Receptor
Image Unavailable

Dopamine (DA) plays an important role in addiction as the dopaminergic reward pathways are targeted by every drug of abuse. So, it is imperative to study this system and its receptors, the dopamine receptors, in order to understand the neurobiological mechanisms that underlie addiction. Specifically, dopamine D2 autoreceptors have been found to play a modulatory role in addiction by regulating dopamine levels [1], drug sensitivity [1] and performance on cognitive tasks [2], shown experimentally through mice knock-out models. Furthermore, drug administration itself has been implicated in modifying these mechanisms, and this modification may underlie the transition from drug use to drug addiction [2]. Recently, research is focusing on investigating the role of genes in addiction and finding genetic markers associated with addiction and the D2 autoreceptor [3][4].

Bibliography
1. Bello, E. P., Mateo, Y., Gelman, D. M., Noaín, D., Shin, J. H., Low, M. J., … & Rubinstein, M. (2011). Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors. Nature neuroscience, 14(8), 1033-1038.
2. Briand, L. A., Flagel, S. B., Garcia-Fuster, M. J., Watson, S. J., Akil, H., Sarter, M., & Robinson, T. E. (2008). Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine. Neuropsychopharmacology, 33(12), 2969-2980.
3. Shumay, E., Fowler, J. S., Wang, G. J., Logan, J., Alia-Klein, N., Goldstein, R. Z., … & Volkow, N. D. (2012). Repeat variation in the human PER2 gene as a new genetic marker associated with cocaine addiction and brain dopamine D2 receptor availability. Translational psychiatry, 2(3), e86.
4. Clarke, T. K., Weiss, A. R., Ferarro, T. N., Kampman, K. M., Dackis, C. A., Pettinati, H. M., … & Berrettini, W. H. (2014). The Dopamine Receptor D2 (DRD2) SNP rs1076560 is Associated with Opioid Addiction. Annals of human genetics, 78(1), 33-39.


Treatment of Addiction

main article: Treatment of Addiction
author: Kristina Niro

Breaking the Cycle of Addiction
Image Unavailable
Recovery involves learning new coping mechanisms to replace drug use Source: Sunshine Coast

Current treatments for addiction include both behavioural and pharmacological approaches, targeting learning and memory processes as well as physiological and psychological dependence. Although progress is being made, treatment efficacy is still limited and many who seek treatment will relapse. Successful recovery often requires the incorporation of multiple methods to create a holistic treatment plan that considers the highly complex nature of addiction. This paper will explore the neurological impact of behavioural methods of treatment[1], as well as the development and future of medications used to inhibit withdrawal symptoms and increase treatment effects. Finally, brain stimulation will be looked at as a way to modify cortical excitability and reduce cravings in recovering addicts, which could help to reduce relapse rates[2].

Bibliography
1. Kaplan, G.B., Heinrichs, S.C., & Carey, R.J. Treatment of addiction and anxiety using extinction approaches: Neural mechanisms and their treatment implications. Pharmacol. Biochem. Behav. 97, 619-625 (2011).
2. Feil, J. & Zangem, A. Brain stimulation in the study and treatment of addiction. Neurosci Biobehav R. 34, 559-574 (2010).



Add a New Comment
_a
Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License